E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 1/22/2010 in the Prospect News PIPE Daily.

New Issue: Lifevantage settles $1.26 million placement of convertible debentures

By Devika Patel

Knoxville, Tenn., Jan. 22 - Lifevantage Corp. sold $1.26 million of 8% convertible debentures in a private placement on Wednesday, according to an 8-K filed Friday with the Securities and Exchange Commission.

The two-year debentures are initially convertible into common stock at $0.20 per share.

The debentures are callable at par if the company meets certain equity conditions.

The investors also received 50% warrant coverage, or warrants for 3,142,500 shares. The warrants are each exercisable at $0.50.

Greenwood Village, Colo.-based Lifevantage specializes in health products.

Issuer:Lifevantage Corp.
Issue:Convertible debentures
Amount:$1,255,743
Maturity:Two years
Coupon:8%
Price:$1,257,000
Conversion price:$0.20
Call option:At par once certain equity conditions are met
Warrants:For 3,142,500 shares
Warrant strike price:$0.50
Settlement date:Jan. 20
Stock symbol:OTCBB: LFVN
Stock price:$0.30 at close Jan. 20
Market capitalization:$18.8 million

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.